1-5 of 5
Stéphane Bouchet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Personalized Daily Doses of Imatinib By Therapeutic Drug Monitoring Increase the Rates of Molecular Responses in Patients with Chronic Myeloid Leukemia. Final Results of the Randomized OPTIM Imatinib Study

Philippe Rousselot, MD PhD, Hyacinthe Johnson-Ansah, MD, Françoise Huguet, MD, Laurence Legros, MD, Martine Escoffre-Barbe, Martine Gardembas, MD, Pascale Cony-Makhoul, MD, Valérie Coiteux, MD, Laurent Sutton, MD, Wajed Abarah, MD, Camille Pouaty, MD, Jean Michel Pignon, MD, Bachra Choufi, MD, Sorin Visanica, MD, Bénédicte Deau, MD, Stephane Bouchet, MDPhD, Francois Guilhot, MD, Francois-Xavier Mahon, MD PhD Professor, Laure Morisset, Jean-Michel Cayuela, Benjamin Maneglier, MD
Journal: Blood
Blood (2015) 126 (23): 133.
https://doi.org/10.1182/blood.V126.23.133.133
Published: 2015
Journal Articles

Pharmacologic Monitoring of Dasatinib As First Line Therapy in Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CP-CML) Identifies Patients At Higher Risk of Pleural Effusion: A Sub-Analysis of the OPTIM-Dasatinib Trial

Philippe Rousselot, MD, PhD, Luigina Mollica, MD, FRCPC, PhD, Gabriel Etienne, MD, PHD, Stephane Bouchet, Agnès Guerci, MD, Franck E Nicolini, MD, PhD, Emmanuelle Chauzit, MD, Pascale Cony-Makhoul, MD, Valérie Coiteux, MD, Martine Gardembas, MD, Laurence Legros, MD, PhD, Lydia Roy, MD, Aude Charbonnier, MD, PhD, Caroline Dartigeas, MD, Jean-Michel Cayuela, PhD, Lambert Busque, MD, Mathieu Molimard, MD, PhD, Joelle Guilhot, PhD, Francois Guilhot, Francois-Xavier Mahon, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3770.
https://doi.org/10.1182/blood.V120.21.3770.3770
Published: 2012
Journal Articles

Imatinib and Nilotinib Intracytoplasmic Determination Levels.

Stephane Bouchet, Stephanie Dulucq, Karine Titier, Nicholas Moore, Mathieu Molimard, Francois-Xavier Mahon
Journal: Blood
Blood (2009) 114 (22): 2750.
https://doi.org/10.1182/blood.V114.22.2750.2750
Published: 2009
Journal Articles

Management of Chronic Myelogenous Leukemia Using Therapeutic Drug Monitoring of Imatinib: The French Experience of a Centralized Laboratory

Mathieu Molimard, Stephane Bouchet, Gabriel Etienne, Laurence Legros, Delphine Rea, Francoise Huguet, Karine Titier, Nicholas Moore, Josy Reiffers, Coralie Belanger, Francois-Xavier Mahon
Journal: Blood
Blood (2008) 112 (11): 3222.
https://doi.org/10.1182/blood.V112.11.3222.3222
Published: 2008
Journal Articles

Multidrug resistance gene ( MDR1 ) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

Brief Report
Stéphanie Dulucq, Stéphane Bouchet, Béatrice Turcq, Eric Lippert, Gabriel Etienne, Josy Reiffers, Mathieu Molimard, Maja Krajinovic, François-Xavier Mahon
Journal: Blood
Blood (2008) 112 (5): 2024–2027.
https://doi.org/10.1182/blood-2008-03-147744
Published: 2008